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Background: Reelin expression and function have been extensively studied in the brain, although its expression
has been also reported in other tissues including blood. This raises the possibility that reelin might be able to cross
the blood-brain barrier, which could be functionally relevant. Up-to-date no studies have been conducted to assess
if reelin is present in the blood-brain barrier, which is mainly constituted by tightly packed endothelial cells. In
this report we assessed the expression of reelin in brain capillaries using immunocytochemistry and electron
microscopy.
Results: At the light microscope, reelin immunolabeling appeared in specific endothelial cells in brain areas that
presented abundant diffuse labeling for this protein (e.g., layer I of the cortex, or the stratum lacunosum moleculare
of the hippocampus), while it was mostly absent from capillaries in other brain areas (e.g., deeper cortical layers,
or the CA1 layer of the hippocampus). As expected, at the electron microscope reelin labeling was observed
in neurons of the cortex, where most of the labeling was associated with the rough endoplasmic reticulum.
Importantly, reelin was also observed in some endothelial cells located in small capillaries, which confirmed
the findings obtained at the light microscope. In these cells, reelin labeling was located primarily in caveolae
(i.e., vesicles of transcytosis), and associated with the plasma membrane of the luminal side of endothelial
cells. In addition, some scarce labeling was observed in the nuclear membrane.
Conclusions: The presence of reelin immunolabeling in brain endothelial cells, and particularly in caveolar
vesicles within these cells, suggests that reelin and/or reelin peptides may be able to cross the blood-brain
barrier, which could have important physiological, pathological, and therapeutic implications.
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Reelin is a large extracellular matrix glycoprotein, which
was originally discovered in the mouse brain [1]. This
protein is secreted by Cajal-Retzius cells during brain
development, regulating neural migration and dendritic
spine maturation (see as reviews [2-5]). In the adult
brain, reelin is expressed primarily in cortical and hippo-
campal GABAergic neurons as well as in cerebellar gran-
ule cells [6-10]. In the mature brain, it is involved in a
variety of functions, including the ccontrol of neurotrans-
mitter release [11,12], maturation and stabilization of
dendritic spines [13-15], specification of the molecular* Correspondence: hector.caruncho@usask.ca
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unless otherwise stated.identity of the distal dendritic compartment of pyramidal
neurons [16], regulation of glutamate receptor homeosta-
sis [17], and in the regulation of different aspects of adult
hippocampal neurogenesis [18-25]. However, reelin ex-
pression is not restricted to the central nervous system
(CNS), and has also been observed in the enteric nervous
system [26], blood serum, liver, pituitary pars intermedia,
and adrenal chromaffin cells [27], as well as in platelets
[28], and lymphatic vessels [29,30]. The functional roles of
reelin outside the CNS have been less studied, although it
has been suggested that reelin enhances spreading of
platelets on fibrinogen [28], and participates in the regula-
tion of lymphatic vessel formation [30].
Some ultrastructural studies have focused primarily on
the subcellular expression of reelin in neurons and neuro-
pil within the CNS, where immunolabeling has been
reported in the rough endoplasmic reticulum, axons,ntral. This is an Open Access article distributed under the terms of the Creative
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However, as far as we know there are no reports on the
possible expression of reelin in the main component of
the blood-brain barrier, the brain endothelial cells. The
expression of reelin in this particular type of endothelial
cells, and in specific subcellular compartments within
them, could be related to possible roles for this protein in
the regulation of brain microvasculature (i.e., as it has
been shown for lymphatic vessels), and/or mediating an
interconnection between brain and peripheral tissues
(i.e., being transported by transcytosis). In order to assess
these possibilities we undertook an electron microscopy
study of reelin immunolabeling in brain endothelial cells.
Results and discussion
In this study we focused on reelin immunolabeling in
the adult rat cortex and hippocampus. As shown in pre-
vious studies [6-9,13,34,35], at the light microscope the
most intense reelin labeling was observed in layer I of
the cortex and in the stratum lacunosum moleculare of
the hippocampus, where neuronal and diffuse labeling
were observed (Figure 1). Interestingly, at higher magni-
fication reelin labeling also appeared in some (but not all)
capillaries within areas containing strong diffuse immuno-
labeling, such as layer I of the cortex (Figures 1A-B) and
the stratum lacunosum moleculare of the hippocampus
(Figures 1E-F). On the other hand, reelin-labeled capillar-
ies were not observed in areas lacking diffuse immuno-
staining, such as deeper layers of the cortex, and the CA1
area of the hippocampus (Figures 1C-D, G-H). The fact
that reelin immunostaining was only observed in some
(but not all) capillaries within areas presenting strong dif-
fuse labeling argues in favor of its specificity. In addition,
this also suggests that a possible secretion and/or trans-
port of reelin by endothelial cells may take place primarily
in areas of heavy diffuse reelin staining (i.e., brain areas
where reelin tends to accumulate in the extracellular
matrix) [see reference 32].
Our electron microscopy study confirmed and extended
our findings. As expected, reelin immunostaining was
found in neurons, where labeling was located in discrete
regions of the rough endoplasmic reticulum (Figures 2A-C),
which is in agreement with previous studies [31-35], and
is also consistent with the fact that reelin is an extracellu-
lar matrix protein expressed through the secretory pathway.
Importantly, we have also confirmed that some endothelial
cells associated with small capillaries contain reelin im-
munostaining (Figure 3), while others appear devoid
of labeling (Figure 4). High magnification electron mi-
crographs allowed us the identification of the subcel-
lular distribution of reelin labeling, which was mostly
located inside vesicles of transcytosis (Figures 3B-C, E-F).
In fact, we were able to observe almost all stages of the
transcytosis vesicles, from the formation of one of thesevesicles accumulating reelin immunostaining (Figure 3B),
to reelin-labeled caveolar vesicles located close to the
lumen of the capillary or even showing the opening neck
(Figures 3C, E-F). In addition, reelin labeling was also
found in the endothelial plasma membrane bordering
the capillary lumen (Figures 3E-F), but not in the
abluminal side (Figures 3B-C, E-F). Furthermore, we found
some punctual labeling in the nuclear envelope, which
may suggest a possible synthesis of reelin by endothelial
cells; although we did not observe immunolabeling in the
Golgi complex of these cells, which is poorly developed.
Finally, we also found capillaries completely devoid of
reelin labeling (Figure 4) in the same electron micros-
copy sample of the cortex, confirming our light micros-
copy observation that reelin appears in some (but not all)
capillaries within the same area.
Although out of the scope of the present work, the
presence of reelin immunolabeling in brain endothelial
cells suggests that this protein may play a role in regulat-
ing the formation of brain microvasculature through a
mechanism similar to the previously reported for lymph-
atic vessels [30]. Interestingly, it has been previously re-
ported that in the cerebral cortex there are differences in
the orientation of the cerebral vasculature between reeler
and wild type mice, which suggests that reelin may be in-
volved in blood vessel development [36]. However, add-
itional experiments will be necessary to test whether reelin
plays a role in the formation of brain microvasculature.
The fact that reelin labeling was observed in caveolar
vesicles in different stages (i.e., from vesicles just formed
close to the abluminal side of the plasma membrane, to
others developing an open neck to the capillary lumen) in-
dicates a possible process of transcytosis, which suggests
that reelin may cross the blood-brain barrier. Alterna-
tively, reelin transport might be also from the brain par-
enchima to the periphery, or may occur in both directions.
Interestingly, it has been shown that apolipoprotein-E
receptor-2 (ApoER2), which together with the very-low-
density-lipoprotein receptor (VLDLR) constitutes the
receptor for reelin, tends to co-immunoprecipitate with
caveolin 1, and to localize in caveolae [37,38]. Taking
together our findings and these previous reports, it is
possible that the crossing of the blood-brain barrier
might be accomplished via a receptor-mediated mechan-
ism that includes ApoER2. In addition, it has been shown
that the adaptor protein DAB1 also tends to cluster within
specific membrane domains (i.e., in detergent-resistant
membrane fractions such as lipid rafts and caveolar vesi-
cles) [39,40], that reelin induces the clustering of its own
receptor Apolipoprotein ER2 and other proteins [41,42],
and that the sorting of these proteins to different mem-
brane domains yields differential endocytosis of reelin
[43]. We have recently shown that deficits in reelin ex-
pression result in changes in membrane protein clustering
Figure 1 Reelin labeling at the light microscope. A) Reelin immunolabeling in superficial and mid-layers of the cortex. As expected, reelin-labeled
neurons are present across different layers of the cortex, and diffuse labeling is mostly present in the superficial layers. B) High magnification of the area
indicated with a dashed-line box in A. This image shows a reelin-immunolabeled blood capillary in layer I of the cortex (empty black arrows). C) Reelin
labeling in deeper layers of the cortex. Scattered reelin-labeled neurons in these deeper layers present moderate labeling compared to superficial layers.
D) High magnification image of the area indicated with a box in C. The capillary is negative for reelin labeling (empty white arrows). E) Reelin labeling
in the lateral part of the rostral hippocampus. Note the row of lightly reelin-labeled neurons in the CA1, as well as the diffuse reelin immunolabeling in
the stratum lacunosum moleculare (slm). F) High magnification image of an area neighboring the slm, corresponding to the dashed-line area indicated
in E. Note the intense reelin labeling surrounding this capillary (empty black arrow). In addition there is a strongly labeled neuron in close proximity
(black arrowhead). G) Reelin labeling in the medial part of the rostral hippocampus. The corpus callosum (cc) appears dorsally bordering the
hippocampus. H) High magnification image of the dashed-line box area in G. Note the unlabeled capillary (empty white arrow) located
in close proximity to a strongly labeled neuron (black arrowhead). cc: corpus callosum; CA1: Cornu Ammonis layer I; slm: stratum lacunosum
moleculare. Scale bars: 10 microns in A, C, G, E; 100 microns in B, D, F, H.
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recombinant reelin to synaptosomes increase protein ex-
pression and alters membrane protein clustering [45,46].
Interestingly, there is a decrease in reelin expression in the
brain and periphery of patients diagnosed with depression
[47,48], and we have found alterations in membrane
protein clustering in lymphocytes from patients with de-
pression, which correlated with therapeutic response toantidepressants [49,50]. All these evidence point towards
an important role for reelin in membrane protein cluster-
ing in both brain and periphery. The presence of reelin
in caveolar vesicles of brain endothelial cells suggests
a possible role for this protein in the regulation of the
crosstalk between brain and immune system, and in the
perturbation of this crosstalk in several psychiatric dis-
orders. Although the specific consequences of reelin
Figure 2 Reelin neuronal labeling at the electron microscope. A) Low magnification electron microscopy image of a reelin immunolabeled
neuron in the cortex. B-C) Detail images of the areas indicated with dashed-line boxes in A. Note that reelin labeling is specifically located in
the rough endoplasmic reticulum (outlined black arrows). m: myelinated process; n: nucleus; p: neuronal process. Scale bars: 2 microns in
A; 0.5 microns in B-C.
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and it should be also taken into account that reelin
deficits could be associated with brain cell malfunc-
tion independent of its association with the blood-brain
barrier.
It does not escape to us that if reelin was able to cross
the blood-brain barrier, it would be easier to design reelin
peptides as possible therapeutic agents for psychiatric
disorders. This is of particular interest taking into ac-
count that overexpression of reelin has been shown
to prevent behavioral phenotypes in animal models of
mood and psychotic disorders [51].
Conclusions
Reelin immunolabeling is specifically present in caveolar
vesicles within endothelial cells located in brain areas
that present strong reelin labeling in the extracellular
matrix. In addition, electron microscopy images evidence
that reelin-labeled caveolar vesicles can be observed from
their formation to the opening of their membrane towards
the capillary lumen. Altogether, these observations suggestthat reelin and/or reelin peptides might cross the blood-
brain barrier, which could have important physiological,
pathological, and therapeutic implications.
Methods
Tissue preparation
Rat brain samples were obtained from adult male rats
(Charles River, Montreal, Canada) weighting between
225 and 250 grams at arrival to the animal facility. Ani-
mals were kept in a 12/12 hour night/day cycle with
water and food ad libitum until endpoint. The rat brain
tissue used in this study belonged to a stock of spare
samples prepared for light and electron microscopy.
Procedures for tissue collection were approved by the
University of Saskatchewan Committee on Animal Care
and Supply, in strict accordance with the Canadian Council
on Animal Care Guidelines. The protocols used in this
study were also in accordance with the Institutional Animal
Care and Use Committee (IACUC) guidelines at the
University of Alabama at Birmingham, and the National
Institutes of Health guidelines for the care and use of
Figure 3 Reelin labeling in endothelial cells. A) Low magnification electron microscopy image of a reelin-labeled endothelial cell in the cortex.
This endothelial cell presents a thin cytoplasm, which is clearly delimited by the basement membrane (white arrowheads) in the abluminal side.
The nucleus (n) occupies most of the cell body of the endothelial cell. B-C) Details of the areas marked with dashed-lined boxes in A. In B, a
reelin-labeled transcytosis vesicle (outlined black arrow) is located in a narrow cytoplasm area between the nucleus (n) and the cell membrane
(white arrowheads). In C, a small cluster of reelin-labeled caveolar vesicles is shown (outlined black arrows), with one of them presenting the open
neck towards the capillary lumen (outlined black arrowhead). Note also that the abluminal side (white arrowheads) is devoid of labeling. D) Reelin
labeling in a small brain capillary in the cortex. This capillary is formed by the almost-continuous thin cytoplasm of a reelin-labeled endothelial
cell. Note also the lack of labeling in myelinated processes (m) located in the vicinity of this capillary. E-F) Detail images of the areas indicated
by dashed-line boxes in D. Reelin-labeled caveolar vesicles are present in different stages. A labeled caveolar vesicle in E (outlined black
arrow) presents a well-delineated oval shape, while a labeled caveolar vesicle in F that is located in close proximity to the luminal side of
the capillary is about to form the open neck (outlined black arrowhead). Note also the presence of reelin labeling in the luminal side of
the membrane (outlined black stars), and the lack of labeling in the abluminal side (white arrowheads). m: myelinated process; n: nucleus.
Scale bars: 2 microns in A, D; 0.5 microns in B-C and E-F.
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deeply anesthetized with sodium pentobarbital and trans-
cardially perfused with saline solution (0.9% NaCl),
followed by 4% paraformaldehyde in 0.1 M phosphate buf-
fer (PB), pH 7.4. Brains were post-fixed in 4% paraformal-
dehyde for 72 hr at 4°C, thoroughly rinsed in PB and
stored in PB containing 0.02% sodium azide. Brain sec-
tions (50 micron thick) were obtained in the coronal plane
on a vibrating microtome. Sections at the level of therostral hippocampus were used for light and electron
microscopy.
Light Microscopy immunohistochemistry
Free-floating sections were thoroughly rinsed in 0.01 M
phosphate buffered saline (PBS) pH 7.4, and subse-
quently treated with 0.3% (v/v) H2O2 in PBS for 30 min
to block endogenous peroxidase activity. They were
then pre-incubated for 30 min in a blocking solution
Figure 4 Reelin labeling is not present in all endothelial cells. A) Low magnification image of an unlabeled brain capillary in the cortex. The
wall of this brain capillary is lined by at least two endothelial cells, as shown by the presence of their nuclei (n). Note also the presence of unlabeled
myelinated (m) and non-myelinated (p) neuronal processes. The basement membrane was also clearly present (white arrowheads). B-C) Detail images
of areas indicated with dashed-lined boxes in A. In B, a caveolar vesicle is clearly unlabeled (white arrow). In B and C, the luminal side of the endothelial
cell membrane is also devoid of labeling (white stars). m: myelinated process; n: nucleus; p: neuronal process. White arrowheads indicate the
membrane in the abluminal side Scale bars: 2 microns in A; 0.5 microns in B-C.
Perez-Costas et al. BMC Neuroscience  (2015) 16:16 Page 6 of 8containing 0.3% Triton X-100, 5% normal horse serum
(NHS; Vector Laboratories, Burlingame, CA, USA), and
1% bovine serum albumin (BSA) dissolved in PBS in order
to block any non-specific antibody binding. The sections
were then incubated with a mouse monoclonal anti-reelin
antibody (Millipore clone G-10 Cat# MAB5364, RRID:
AB_2179313; diluted 1:2000, 48 hr, at 4°C). This incuba-
tion was followed by three rinses in PBS and incubation
for 1 hour at room temperature with a biotinylated horse
anti-mouse secondary antibody (Vector Laboratories) di-
luted 1:200 in PBS containing 0.3% (v/v) Triton X-100.
After several rinses in PBS, the sections were incubated
with a peroxidase-coupled avidin-biotin complex (Vecta-
Stain Elite ABC Kit, Vector Laboratories) for 90 minutes at
room temperature. To visualize the immunolabeling, the
sections were developed using a solution of 0.033% 3,3’-
diaminobenzidine (DAB) and 0.00786% H2O2 prepared
in PBS. The reaction was stopped using PBS as a rinse.
The sections were then mounted onto slides, allowed to
dry overnight, dehydrated in ethanol, cleared in xyleneand coverslipped using Entellan resin (Millipore, USA).
Omission of the primary antibody resulted in a complete
lack of immunostaining (not shown). In addition, label-
ing with a different anti-reelin primary antibody (Reln
AB142) yielded similar results than those obtaining using
the G-10 anti-reelin antibody (data not shown).
Light microscopy images of reelin immunolabeling were
obtained using a computerized Nikon E800 microscope.
Electron Microscopy immunohistochemistry
Free-floating sections were treated with 1% sodium bo-
rohydride in PBS for 15 minutes and thoroughly rinsed
in PBS (5 rinses, 5 min each). Endogenous peroxidase
was blocked by immersing the sections in a solution of
5% hydrogen peroxide in PBS for 30 minutes, which was
followed by 5 rinses (5 min each) in PBS. Afterwards, to
block non-specific binding sites in the sections, a block-
ing solution of 10% NHS prepared in PBS containing
0.1% Triton X-100 was applied for one hour. The sec-
tions were then incubated for 72 hours at 4°C with a
Perez-Costas et al. BMC Neuroscience  (2015) 16:16 Page 7 of 8mouse monoclonal anti-reelin antibody (Millipore clone
G-10 Cat# MAB5364, RRID:AB_2179313clone) diluted
1:1000 in PBS containing 5% NHS. After 5 rinses (5 min
each) in PBS, the sections were incubated with a biotinylated
horse anti-mouse secondary antibody (Vector Laboratories)
diluted 1:400 for 45 minutes at room temperature, and
rinsed in PBS (5 times, 5 min each). Finally, the sections
were incubated for 45 minutes with a peroxidase-coupled
avidin-biotin complex (Vecta-Stain Elite ABC Kit, Vector
Laboratories), rinsed in PBS, and the reaction was devel-
oped using a 3-3’ diaminobenzidine-peroxidase kit (DAB-
peroxidase kit, Vector Laboratories). The reaction was
stopped by rinsing the sections in PBS, and the sections
were further rinsed in PB prior to embedding for electron
microscopy. After immunocytochemistry, all sections for
electron microscopy were postfixed overnight at 4°C in 2%
glutaraldehyde prepared in PB.
Sections were embedded for electron microscopy as
previously described in Perez-Costas et al [52], with some
modifications. After several rinses in PB, immunolabeled
sections were immersed in a solution of 1% osmium tet-
roxide in PB for 1 hour at room temperature, rinsed in PB
two times (5 min each), and gradually dehydrated in a
series of ethanol (30%, 50%, 70% v/v of ethanol in milli-Q
ultrapure water). After this partial dehydration, sections
were stained with a solution of 1% uranyl acetate in
70% ethanol for 1 hour at room temperature, and then
dehydration was completed by immersing the sections
gradually in 90% and 100% ethanol (3 baths, 5 min each).
After dehydration the sections were cleared in propylene
oxide (2 baths, 5 min each), progressively infiltrated at
room temperature with Epon resin diluted in propylene
oxide (1:1 v/v propylene oxide/resin, 30 minutes; followed
by v/v 1:2 propylene oxide/resin, 1 hour). Finally, the
sections were immersed in pure Epon resin overnight at
4°C, transferred to freshly-prepared Epon resin for flat-
embedding, and allowed to polymerize in an oven set at
60°C for 72 hours. In order to select the regions of interest
(i.e. frontal cortex), the embedded sections were visualized
on a Nikon Eclipse 50 I light microscope, carefully identi-
fying the cortical region of interest, and re-dissecting this
region for ultramicrotomy. Ultrathin sections (90 nm
thick) were obtained using a Leica UC6 ultramicrotome
(Leica Microsystems, Wetzlar, Germany) and mounted on
copper-slot grids (Electron Microscopy Sciences, USA).
Immunolabeled cortex samples were then observed and
photographed using a transmission electron microscope
(H-7650, Hitachi, Japan) equipped with a Hamamatsu
Orca HR digital camera (Hamamatsu, Japan).
Photomontage and lettering
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ing were done using Corel Draw X5 (Corel Corporation,
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